Can sputum eosinophils predict a poor response to mepolizumab?

J Allergy Clin Immunol. 2024 Apr 23:S0091-6749(24)00415-9. doi: 10.1016/j.jaci.2024.04.013. Online ahead of print.

Authors

Catherine Lemiere¹, James G Martin²

Affiliations

¹ CIUSS du Nord de l'île de Montréal, Université de Montréal, Montréal, Québec, Canada. Electronic address: catherine.lemiere@umontreal.ca.
² McGill University Health Centre Research Institute and McGill University, Montréal, Québec, Canada.

PMID: 38663816
DOI: 10.1016/j.jaci.2024.04.013

No abstract available

Keywords: CD62L expression; Severe asthma; mepolizumab; sputum eosinophils.

Publication types

Editorial